These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8624081)

  • 61. Facing the complexity of Alzheimer's disease.
    Dallemagne P; Rochais C
    Future Med Chem; 2020 Feb; 12(3):175-177. PubMed ID: 31747794
    [No Abstract]   [Full Text] [Related]  

  • 62. Predicting positivity for a new era of Alzheimer disease prevention trials.
    Burns JM; Klunk WE
    Neurology; 2012 Oct; 79(15):1530-1. PubMed ID: 22972636
    [No Abstract]   [Full Text] [Related]  

  • 63. [Generation of disease-specific amyloid structures and analysis of pathogenesis].
    Yabuki Y
    Nihon Yakurigaku Zasshi; 2024; 159(5):341. PubMed ID: 39218682
    [No Abstract]   [Full Text] [Related]  

  • 64. Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.
    Jones SE; Harvey PD
    Transl Psychiatry; 2023 Mar; 13(1):100. PubMed ID: 36973270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.
    Ovsepian SV; O'Leary VB; Zaborszky L
    Neuroscientist; 2016 Jun; 22(3):238-51. PubMed ID: 26002948
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease.
    Kramberger MG; Jelic V; Kåreholt I; Enache D; Eriksdotter Jönhagen M; Winblad B; Aarsland D
    Dement Geriatr Cogn Dis Extra; 2012 Jan; 2(1):48-56. PubMed ID: 22649429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.
    Potter PE; Rauschkolb PK; Pandya Y; Sue LI; Sabbagh MN; Walker DG; Beach TG
    Acta Neuropathol; 2011 Jul; 122(1):49-60. PubMed ID: 21533854
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The application of positron-emitting molecular imaging tracers in Alzheimer's disease.
    Cohen RM
    Mol Imaging Biol; 2007; 9(4):204-16. PubMed ID: 17354042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing.
    von Arnim CA; Spoelgen R; Peltan ID; Deng M; Courchesne S; Koker M; Matsui T; Kowa H; Lichtenthaler SF; Irizarry MC; Hyman BT
    J Neurosci; 2006 Sep; 26(39):9913-22. PubMed ID: 17005855
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Beta-amyloid and cholinergic neurons.
    Dolezal V; Kasparová J
    Neurochem Res; 2003 Apr; 28(3-4):499-506. PubMed ID: 12675138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amyloid beta peptide impaired carbachol but not glutamate-mediated phosphoinositide pathways in cultured rat cortical neurons.
    Huang HM; Ou HC; Hsieh SJ
    Neurochem Res; 2000 Feb; 25(2):303-12. PubMed ID: 10786716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway.
    Mills J; Laurent Charest D; Lam F; Beyreuther K; Ida N; Pelech SL; Reiner PB
    J Neurosci; 1997 Dec; 17(24):9415-22. PubMed ID: 9390997
    [TBL] [Abstract][Full Text] [Related]  

  • 73. From acetylcholine to amyloid: neurotransmitters and the pathology of Alzheimer's disease.
    Nitsch RM
    Neurodegeneration; 1996 Dec; 5(4):477-82. PubMed ID: 9117566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors.
    Lee RK; Wurtman RJ
    Ann N Y Acad Sci; 2000; 920():261-8. PubMed ID: 11193162
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of APP processing. Potential for the therapeutical reduction of brain amyloid burden.
    Nitsch RM; Wurtman RJ; Growdon JH
    Ann N Y Acad Sci; 1996 Jan; 777():175-82. PubMed ID: 8624081
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices.
    Nitsch RM; Slack BE; Farber SA; Schulz JG; Deng M; Kim C; Borghesani PR; Korver W; Wurtman RJ; Growdon JH
    J Neural Transm Suppl; 1994; 44():21-7. PubMed ID: 7897393
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease.
    Nitsch RM; Wurtman RJ; Growdon JH
    Arzneimittelforschung; 1995 Mar; 45(3A):435-8. PubMed ID: 7763340
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.